| 11149043 |
Prodrug modulators of the integrated stress pathway |
Michael J. Dart, Jennifer M. Frost, Yunsong Tong, Xiangdong Xu, Lei Shi +4 more |
2021-10-19 |
|
| 10053474 |
Anti-viral compounds |
Jaclyn Chau, Hui-Ju Chen, David A. DeGoey, John Hartung, Nathan Ide +12 more |
2018-08-21 |
$1,066,612,000 |
| 8859549 |
Potassium channel modulators |
Tongmei Li, Sridhar Peddi, Arturo Perez-Medrano, David A. DeGoey |
2014-10-14 |
$91,234,000 |
| 8815930 |
Compounds that inhibit TRPV1 and uses thereof |
Chih-Hung Lee, Richard J. Perner, John Darbyshire |
2014-08-26 |
$130,577,000 |
| 8629143 |
Potassium channel modulators |
Tongmei Li, Arturo Perez-Medrano, Sridhar Peddi |
2014-01-14 |
$139,158,000 |
| 8598220 |
Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof |
John R. Koenig, Arthur Gomtsyan, Chih-Hung Lee |
2013-12-03 |
$87,921,000 |
| 8440691 |
Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
Arthur Gomtsyan, Erol K. Bayburt, Robert G. Schmidt, Chih-Hung Lee, Tammie K. Jinkerson +3 more |
2013-05-14 |
$464,317,000 |
| 8232309 |
Prodrugs of compounds that inhibit TRPV1 receptor |
Arthur Gomtsyan, Erol K. Bayburt, John R. Koenig, Kennan C. Marsh, Robert G. Schmidt +3 more |
2012-07-31 |
$42,316,000 |
| 7998982 |
Amide derivatives as TRPV1 antagonists |
Anil Vasudevan, Jerome F. Daanen, Arthur Gomtsyan, Tammie K. Jinkerson, Ryan G. Keddy +3 more |
2011-08-16 |
$18,160,000 |
| 7812019 |
Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
Arthur Gomtsyan, Erol K. Bayburt, Robert G. Schmidt, Chih-Hung Lee, Tammie K. Jinkerson +3 more |
2010-10-12 |
$27,565,000 |
| 7767705 |
Compounds that inhibit TRPV1 and uses thereof |
Chih-Hung Lee, Richard J. Perner, John Darbyshire |
2010-08-03 |
$35,803,000 |
| 7622493 |
Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof |
John R. Koenig, Arthur Gomtsyan, Chih-Hung Lee |
2009-11-24 |
$113,624,000 |
| 7615570 |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof |
Tammie K. Jinkerson, Ryan G. Keddy, Chih-Hung Lee |
2009-11-10 |
$172,532,000 |
| 7595332 |
Amides that inhibit vanilloid receptor subtype 1 (VR1) |
Chih-Hung Lee, John R. Koenig |
2009-09-29 |
$234,639,000 |
| 7348343 |
Amides useful for treating pain |
Guo Zhu Zheng, Sean Colm Turner, Tammie White, Robert G. Schmidt, John R. Koenig +1 more |
2008-03-25 |
$191,769,000 |
| 7129235 |
Amides useful for treating pain |
Guo Zhu Zheng, Sean Colm Turner, Tammie White, Robert G. Schmidt, John R. Koenig +1 more |
2006-10-31 |
$65,822,000 |
| 7037927 |
Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Chih-Hung Lee, John R. Koenig |
2006-05-02 |
$56,784,000 |
